RSV RESPIRATORY SYNCYTIAL VIRUS

Clinical trials for RSV RESPIRATORY SYNCYTIAL VIRUS explained in plain language.

Never miss a new study

Get alerted when new RSV RESPIRATORY SYNCYTIAL VIRUS trials appear

Sign up with your email to follow new studies for RSV RESPIRATORY SYNCYTIAL VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New RSV vaccine candidate aims to shield older adults from severe lung infections

⭐️ VACCINE ⭐️ Recruiting now

This study tests an experimental vaccine called AZD6489 in adults aged 60 and older. The vaccine is designed to protect against respiratory syncytial virus (RSV), a common virus that can cause serious lung infections in older people. Participants receive a single injection of eit…

Matched conditions: RSV RESPIRATORY SYNCYTIAL VIRUS

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: ⭐️ VACCINE ⭐️

Last updated Jul 23, 2026 00:00 UTC

RSV RESPIRATORY SYNCYTIAL VIRUS

Get alerted when new RSV RESPIRATORY SYNCYTIAL VIRUS trials appear

New RSV vaccine candidate aims to shield older adults from severe lung infections